FDA OKs another Pfizer, Moderna COVID booster for 50 and up
The Food and Drug Administration’s decision aims to offer extra protection to the most vulnerable in case the virus rebounds.
The FDA said Tuesday that those people can seek a fourth dose several months after their previous booster.
With COVID-19 cases currently low, it’s not clear if they should rush out and get one.
There’s limited evidence to tell how much benefit another booster could offer right now.
The FDA ruled without input from its independent advisers.